Open Access

Statin/ezetimibe combinations: data and evidence, for which patients.

Congress Session

About the speaker

Professor Alberto Zambon

University Hospital of Padova, Padua (Italy)
7 presentations
0 follower

6 more presentations in this session

ESC Guidelines 2019: what has changed?

Speaker: Professor A. Zambon (Padua, IT)

Thumbnail

What is the key evidence supporting LDL-C control at lower targets, with earlier intervention for better outcomes in the long-term?

Speaker: Professor L. Perez De Isla (Madrid, ES)

Thumbnail

Broader usage of combinations in daily clinical practice: what benefits for patients?

Speaker: Professor A. Zambon (Padua, IT)

Thumbnail

How have the French and Spanish (local) Cardiology Societies interpreted the ESC Guidelines? Insights and recommendations.

Speaker: Professor L. Perez De Isla (Madrid, ES)

Thumbnail

Feedback on patients treated with high intensity statin/ezetimibe combinations. Do we need to go further?

Speaker: Professor A. Zambon (Padua, IT)

Thumbnail

Access the full session

Choosing the best treatment approach to dyslipidemia: monotherapy vs combination therapy

Speakers: Professor A. Zambon, Professor A. Zambon, Professor L. Perez De Isla, Professor A. Zambon, Professor L. Perez De Isla...
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

ESC Premium Access

Changes in EPA and DHA during supplementation with Omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial

27 August 2021

ESC Premium Access

The prevalence of statin intolerance worldwide: a systematic review and meta-analysis with 4,143,517 patients

27 August 2021

ESC Premium Access

Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.

27 August 2021

This platform is supported by

logo Novo Nordisk